Head-To-Head Survey: Owlet (OWLT) and Its Peers

Owlet (NYSE:OWLT) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its rivals? We will compare Owlet to related companies based on the strength of its institutional ownership, profitability, earnings, risk, dividends, valuation and analyst recommendations.

Valuation & Earnings

This table compares Owlet and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Owlet	$105.70 million	-$39.68 million	-5.41
Owlet Competitors	$1.88 billion	$139.14 million	10.75

Owlet’s rivals have higher revenue and earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Volatility & Risk

Owlet has a beta of 1.91, suggesting that its share price is 91% more volatile than the S&P 500. Comparatively, Owlet’s rivals have a beta of 5.47, suggesting that their average share price is 447% more volatile than the S&P 500.

Profitability

This table compares Owlet and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Owlet	-8.61%	-601.24%	-15.96%
Owlet Competitors	-278.23%	-150.07%	-21.87%

Analyst Recommendations

This is a summary of current ratings and target prices for Owlet and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owlet	1	1	3	0	2.40
Owlet Competitors	4252	10480	18203	824	2.46

Owlet currently has a consensus target price of $15.00, suggesting a potential upside of 269.91%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 25.49%. Given Owlet’s higher possible upside, research analysts plainly believe Owlet is more favorable than its rivals.

Institutional & Insider Ownership

72.6% of Owlet shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 36.2% of Owlet shares are held by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Owlet rivals beat Owlet on 7 of the 13 factors compared.

About Owlet

Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, oxygen, activity, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah.